GENUINE progress
TG Therapeutics' GENUINE trial shows that ublituximab plus ibrutinib improves survival in patients with chronic lymphocytic leukemia
Bacteria engineered to produce therapeutics fill a niche for patients with unmet medical needs.
View ArticleBiobanking gives scientists access to thousands of biological samples, moving precision medicine one step closer to reality.
View Infographic